Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer

PURPOSE: The aim of our study was to evaluate if therapeutic success in the first-line of anticancer treatments in patients with NSCLC may predict treatment success in the following lines. METHODS: We analyzed the data of patients with NSCLC stage III/IV from the TULUNG registry separately for chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bratova, Monika, Skrickova, Jana, Matusikova, Magda, Hrabcova, Karolina, Havel, Libor, Koubkova, Leona, Hrnciarik, Michal, Krejci, Jana, Fischer, Ondrej, Svaton, Martin, Brat, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657273/
https://www.ncbi.nlm.nih.gov/pubmed/37768380
http://dx.doi.org/10.1007/s00432-023-05431-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657273/
https://www.ncbi.nlm.nih.gov/pubmed/37768380
http://dx.doi.org/10.1007/s00432-023-05431-5

Ejemplares similares